Literature DB >> 26211823

Postmenopausal breast cancer: a best endocrine strategy?

Erica L Mayer1, Harold J Burstein2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26211823     DOI： 10.1016/S0140-6736(15)61206-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.

Authors:  Joachim Diessner; Manfred Wischnewsky; Maria Blettner; Sebastian Häusler; Wolfgang Janni; Rolf Kreienberg; Roland Stein; Tanja Stüber; Lukas Schwentner; Catharina Bartmann; Achim Wöckel
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

Review 2.  An update on the management of breast cancer in Africa.

Authors:  V Vanderpuye; S Grover; N Hammad; H Simonds; F Olopade; D C Stefan
Journal:  Infect Agent Cancer       Date:  2017-02-14       Impact factor: 2.965

Review 3.  Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case-Control Studies.

Authors:  Agnieszka Barańska; Wiesław Kanadys
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.